Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Phenytoin for neuroprotection - Authors' reply.
Implementation of a Coherent Anti-Stokes Raman Scattering (CARS) System on a Ti:Sapphire and OPO Laser Based Standard Laser Scanning Microscope.
Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
The MS Center of Saint Louis: a practice perspective of the impacts of high cost sharing.
Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
Effects of a home-based upper-limb training program in patients with Multiple Sclerosis: a randomized controlled trial.
No evidence of disease activity in multiple sclerosis patients.
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis.
MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.
Synaptic Pathology in the Cerebellar Dentate Nucleus in Chronic Multiple Sclerosis.
Receipt of recommended services among patients with selected disabling conditions and diabetes.
S100A8/A9: From basic science to clinical application.
Corrigendum: Oligodendrocyte, Astrocyte and Microglia Crosstalk in Myelin Development, Damage, and Repair.
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.
Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis.
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
Brain-derived neurotrophic and immunologic factors: beneficial effects of riboflavin on motor disability in murine model of multiple sclerosis.
Neurotrophins' Modulation by Olive Polyphenols.
The 'best' basic science paper on multiple sclerosis in 2012.
Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
Pages
« first
‹ previous
…
764
765
766
767
768
769
770
771
772
…
next ›
last »